Pages that link to "Q34300370"
Jump to navigation
Jump to search
The following pages link to 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. (Q34300370):
Displaying 50 items.
- Brexpiprazole: so far so good (Q26766401) (← links)
- Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role? (Q26864383) (← links)
- Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism (Q28084069) (← links)
- Role of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent Rats (Q28273912) (← links)
- Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future (Q28394341) (← links)
- Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA (Q28484113) (← links)
- Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats (Q28546441) (← links)
- How were new medicines discovered? (Q29616641) (← links)
- SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C (Q30400003) (← links)
- Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. (Q30630808) (← links)
- Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study (Q33186211) (← links)
- Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats (Q33748306) (← links)
- Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans (Q33841432) (← links)
- Classics in Chemical Neuroscience: Aripiprazole. (Q33866125) (← links)
- Effects of aripiprazole on subjective and physiological responses to alcohol (Q34009852) (← links)
- Aripiprazole in autism spectrum disorders and fragile X syndrome (Q34025492) (← links)
- Retrospective case series of aripiprazole augmentation in pervasive developmental disorders (Q34165087) (← links)
- Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy (Q34227284) (← links)
- Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder (Q34333899) (← links)
- Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. (Q34375654) (← links)
- The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys (Q34407060) (← links)
- Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies (Q34605085) (← links)
- Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? (Q35012574) (← links)
- Treatment for mood and anxiety disorders: quetiapine and aripiprazole (Q35176180) (← links)
- Dopamine partial agonists: a new class of antipsychotic (Q35688765) (← links)
- Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function (Q36590407) (← links)
- The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics (Q36677469) (← links)
- Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials (Q36755314) (← links)
- GPCR functional selectivity has therapeutic impact (Q36880909) (← links)
- Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence (Q37133284) (← links)
- Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review (Q37299210) (← links)
- Use of atypical antipsychotics for treatment-resistant major depressive disorder (Q37316104) (← links)
- Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis (Q37665567) (← links)
- Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study (Q37696215) (← links)
- Aripiprazole: a review of its use in the management of schizophrenia in adults (Q37980517) (← links)
- Dopamine receptor signaling and current and future antipsychotic drugs (Q38058009) (← links)
- Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity (Q39244947) (← links)
- Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction (Q39580310) (← links)
- Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone (Q41672253) (← links)
- Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum (Q42481687) (← links)
- Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole (Q42661585) (← links)
- The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine (Q42689992) (← links)
- Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. (Q43107638) (← links)
- Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats (Q44675329) (← links)
- Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. (Q44735526) (← links)
- Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. (Q45916254) (← links)
- Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats. (Q46017126) (← links)
- Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism (Q46260468) (← links)
- Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors (Q46446352) (← links)
- Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats (Q46605166) (← links)